Skip to main content

As vaccine makers seek full FDA approval, how will it impact hesitancy?

Dr. Bill Hartman is the principal investigator for UW-Health’s vaccine trials. He says full approval requires the vaccine makers to provide much more data than what was considered for the EUA.